CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Tumor-infiltrating CD8+ T cells are strongly associated with patient survival in a wide variety of human cancers. Less is known about tumor-infiltrating CD20+ B cells, which often colocalize with T cells, sometimes forming organized lymphoid structures. In autoimmunity and organ transplantation, T cells and B cells collaborate to generate potent, unrelenting immune responses that can result in extensive tissue damage and organ rejection. In these settings, B cells enhance T cell responses by producing Abs, stimulatory cytokines, and chemokines, serving as local APCs, and organizing the formation of tertiary lymphoid structures that sustain long-term immunity. Thus, B cells are an important component of immunological circuits associated with persistent, rampant tissue destruction. Engagement of tumor-reactive B cells may be an important condition for generating potent, long-term T cell responses against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
Sarwal, M., Chua, M.-S., Kambham, N., Hsieh, S.-C., Satterwhite, T., Masek, M., & Salvatierra, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035588 · Cited by 701
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Cytokine-producing B lymphocytes-key regulators of immunity
Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556
Cited by
Items 101–200 of 461
Zhang, S., Liu, Z., Wu, D., Chen, L., & Xie, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596318 · Cited by 78
Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer
Yang, C., Lee, H., Jove, V., Deng, J., Zhang, W., Liu, X., Forman, S., Dellinger, T. H., Wakabayashi, M., Yu, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054029 · Cited by 72
Siliņa, K., Rulle, U., Kalniņa, Z., & Linē, A. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1544-9 · Cited by 78
Xue, H., Lin, F., Tan, H., Zhu, Z.-Q., Zhang, Z.-Y., & Zhao, L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154815 · Cited by 74
Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ
Miligy, I. M., Mohan, P., Gaber, A., Aleskandarany, M. A., Nolan, C. C., Diez, M., Mukherjee, A., Chapman, C. J., Ellis, I. O., Green, A. R., et al. (2017) · Histopathology · doi:10.1111/his.13217 · Cited by 77
T‐ and B‐cell subsets in periodontitis
Gonzales, J. R. (2015) · Periodontology 2000 · doi:10.1111/prd.12090 · Cited by 75
Mao, Y., Wang, Y., Dong, L., Zhang, Q., Wang, C., Zhang, Y., Li, X., & Fu, Z. (2019) · Cancer Science · doi:10.1111/cas.14122 · Cited by 73
Behr, D. S., Peitsch, W. K., Hametner, C., Lasitschka, F., Houben, R., Schönhaar, K., Michel, J., Dollt, C., Goebeler, M., Marx, A., et al. (2014) · Europe PMC (PubMed Central) · Cited by 71
Alexander, P. G., McMillan, D. C., & Park, J. H. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101949 · Cited by 70
The immunoregulatory mechanisms of carcinoma for its survival and development
Du, C., & Wang, Y. Z. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-12 · Cited by 69
Current State of Biomarkers in Ovarian Cancer Prognosis
Au, K. K., Josahkian, J. A., Francis, J., Squire, J. A., & Koti, M. (2015) · Future Oncology · doi:10.2217/fon.15.251 · Cited by 68
Svensson, M. C., Warfvinge, C. F., Fristedt, R., Hedner, C., Borg, D., Eberhard, J., Micke, P., Nodin, B., Leandersson, K., & Jirström, K. (2017) · Oncotarget · doi:10.18632/oncotarget.19437 · Cited by 67
Schneider, K., Marbaix, É., Bouzin, C., Hamoir, M., Mahy, P., Bol, V., & Grégoire, V. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1445287 · Cited by 66
Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers
Wallis, S. P., Stafford, N. D., & Greenman, J. (2014) · Head & Neck · doi:10.1002/hed.23736 · Cited by 65
Lin, Z., Liu, L., Xia, Y., Chen, X., Xiong, Y., Qu, Y., Wang, J., Bai, Q., Guo, J., & Xu, J. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1477461 · Cited by 65
Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies
Zirakzadeh, A. A., Marits, P., Sherif, A. M., & Winqvist, O. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203279 · Cited by 64
Positive and negative functions of B lymphocytes in tumors
Shen, M., Sun, Q., Wang, J., Pan, W., & Ren, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10094 · Cited by 63
Neuroendocrine Regulation of Tumor-Associated Immune Cells
Colón-Echevarria, C. B., Lamboy-Caraballo, R., Aquino-Acevedo, A. N., & Armaiz-Peña, G. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01077 · Cited by 62
Knief, J., Reddemann, K., Petrova, E., Herhahn, T., Wellner, U. F., & Thorns, C. (2016) · Anticancer Research · doi:10.21873/anticanres.11107 · Cited by 62
Seow, D. Y. B., Yeong, J. P.-S., Lim, J. X., Chia, N., Lim, J. C. T., Ong, C. C. H., Tan, P. H., & Iqbal, J. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05548-y · Cited by 62
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy
Kim, J., & Thomas, S. N. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000500 · Cited by 61
Variation of Tumor-Infiltrating Lymphocytes in Human Cancers: Controversy on Clinical Significance
Sasada, T., & Suekane, S. (2011) · Immunotherapy · doi:10.2217/imt.11.106 · Cited by 61
Lao, X., LIANG, Y.-J., Su, Y., ZHANG, S.-E., ZHOU, X., & Liao, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.4184 · Cited by 61
Zhang, W., Wang, W., Han, X., Gao, H.-L., Xu, S., Li, S., Li, T., Xu, H., Li, H., Ye, L., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001188 · Cited by 61
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Fucikova, J. P., Coosemans, A., Oršulić, S., Cibula, D., Vergote, I. B., Galluzzi, L., & Špíšek, R. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002873 · Cited by 61
Systemic and local immunosuppression in patients with high-grade meningiomas
Li, Y. D., Veliceasa, D., Lamano, J. B., Lamano, J. B., Kaur, G., Biyashev, D., Horbinski, C., Kruser, T. J., & Bloch, O. G. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02342-8 · Cited by 60
Zubair, H., Khan, M. A., Anand, S., Srivastava, S. K., Singh, S., & Singh, A. P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.009 · Cited by 60
Koti, M., Siu, A., Clément, I., Bidarimath, M., Turashvili, G., Edwards, A. K., Rahimi, K., Mes‐Masson, A., & Squire, J. A. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.459 · Cited by 60
Enfield, K. S. S., Martin, S. D., Marshall, E. A., Kung, S. H. Y., Gallagher, P., Milne, K., Chen, Z., Nelson, B. H., Lam, S. C., English, J. C., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0488-6 · Cited by 59
Self-citationCD20+ T cells: an emerging T cell subset in human pathology
Lee, A. Y. S. (2022) · Inflammation Research · doi:10.1007/s00011-022-01622-x · Cited by 58
Testing the cancer stem cell hypothesis in melanoma: The clinics will tell
Shakhova, O., & Sommer, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.009 · Cited by 58
Tumour‐associated B cells in urothelial urinary bladder cancer
Zirakzadeh, A. A., Sherif, A. M., Rosenblatt, R., Bergman, E. A., Winerdal, M., Yang, D., Cederwall, J., Jakobsson, V., Hyllienmark, M., Winqvist, O., et al. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12830 · Cited by 58
Koti, M., Siu, A., Clément, I., Bidarimath, M., Turashvili, G., Edwards, A., Rahimi, K., Masson, A.-M. M., & Squire, J. A. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.81 · Cited by 57
Overcoming Tumor-Mediated Immunosuppression
Schlößer, H., Theurich, S., Shimabukuro‐Vornhagen, A., Holtick, U., Stippel, D. L., & von Bergwelt‐Baildon, M. (2014) · Immunotherapy · doi:10.2217/imt.14.58 · Cited by 57
Centuori, S. M., Gomes, C. J., Kim, S. S., Putnam, C. W., Larsen, B. T., Garland, L. L., Mount, D. W., & Martinez, J. D. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1404-z · Cited by 57
Regulation of Tumor Immunity by Lysophosphatidic Acid
Lee, S. Ç., Dacheux, M. A., Norman, D. D., Balázs, L., Torres, R. M., Augelli‐Szafran, C. E., & Tigyi, G. (2020) · Cancers · doi:10.3390/cancers12051202 · Cited by 57
Au, K. K., Page, C. L., Ren, R., Meunier, L., Clément, I., Tyrishkin, K., Peterson, N. T., Kendall‐Dupont, J., Childs, T. J., Francis, J., et al. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.55 · Cited by 56
Kobayashi, T., Oishi, K., Okamura, A., Maeda, S., Komuro, A., Hamaguchi, Y., Fujimoto, M., Takehara, K., & Matsushita, T. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.016 · Cited by 56
Reed, C. M., Cresce, N. D., Mauldin, I. S., Slingluff, C. L., & Olson, W. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0233 · Cited by 55
The immunological effect of hyaluronan in tumor angiogenesis
Spinelli, F. M., Vitale, D. L., Demarchi, G., Cristina, C., & Alaniz, L. D. (2015) · Clinical & Translational Immunology · doi:10.1038/cti.2015.35 · Cited by 55
B Cells Promote Pancreatic Tumorigenesis
Roghanian, A., Fraser, C., Kleyman, M., & Chen, J. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0100 · Cited by 54
Clinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastric cancer
Wakatsuki, K., Sho, M., YAMATO, I., Takayama, T., Matsumoto, S., Tanaka, T., Migita, K., Ito, M., Hotta, K., & Nakajima, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2302 · Cited by 54
Tumor-infiltrating follicular helper T cells: The new kids on the block
Gu‐Trantien, C., & Willard-Gallo, K. E. (2013) · OncoImmunology · doi:10.4161/onci.26066 · Cited by 53
B cells in lung cancer—not just a bystander cell: a literature review
Leong, T. L., & Bryant, V. L. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-788 · Cited by 53
Tim-3 identifies exhausted follicular helper T cells in breast cancer patients
Zhu, S., Lin, J., Qiao, G., Wang, X., & Xu, Y. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.04.005 · Cited by 51
Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity
Haro, M., Dyevoich, A. M., Phipps, J. P., & Haas, K. M. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0981 · Cited by 51
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Toss, M. S., Abidi, A., Lesche, D., Joseph, C., Mahale, S., Saunders, H., Kader, T., Miligy, I. M., Green, A. R., Gorringe, K. L., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0797-7 · Cited by 52
B cells promote tumor progression in a mouse model of HPV‐mediated cervical cancer
Tang, A., Dadaglio, G., Oberkampf, M., Carlo, S. E. D., Peduto, L., Laubreton, D., Desrues, B., Sun, C., Montagutelli, X., & Leclerc, C. (2016) · International Journal of Cancer · doi:10.1002/ijc.30169 · Cited by 51
Zhou, Z., Tong, D., Guan, J., Tan, H.-W., Zhao, L.-D., Zhu, Y., Yao, J., Yang, J., & Zhang, Z. (2016) · Europe PMC (PubMed Central) · Cited by 51
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Zhang, J., Hu, X. S., Wang, J., Sahu, A. D., Cohen, D., Song, L., Ouyang, Z., Fan, J., Wang, B., Fu, J., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0681-3 · Cited by 50
Zhao, X., Zhu, Y., Zhou, J., Gao, Y., & Liu, F. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105088 · Cited by 50
The Role of Inflammation in Lymphoma
Carbone, A., Tripodo, C., Carlo‐Stella, C., Santoro, A., & Gloghini, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_12 · Cited by 50
Varn, F. S., Andrews, E. H., Mullins, D. W., & Cheng, C. (2016) · Nature Communications · doi:10.1038/ncomms10248 · Cited by 50
Modeling putative therapeutic implications of exosome exchange between tumor and immune cells
Lu, M., Huang, B., Hanash, S., Onuchic, J. N., & Ben‐Jacob, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416745111 · Cited by 49
Porcellato, I., Silvestri, S., Menchetti, L., Recupero, F., Mechelli, L., Sforna, M., Iussich, S., Bongiovanni, L., Lepri, E., & Brachelente, C. (2019) · Veterinary and Comparative Oncology · doi:10.1111/vco.12556 · Cited by 49
Tetraspanins in the immune response against cancer
Veenbergen, S., & van Spriel, A. B. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.03.010 · Cited by 45
Schoenhals, J. E., Seyedin, S. N., Anderson, C., Brooks, E. D., Li, Y. R., Younes, A. I. A., Niknam, S., Li, A., Barsoumian, H. B., Cortez, M. A., et al. (2007) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.03.06 · Cited by 45
T follicular helper and T follicular regulatory cells in colorectal cancer: A complex interplay
Hetta, H. F., Elkady, A., Yahia, R., Meshaal, A. K., Saad, M. M., Mekky, M. A., & Al-Kadmy, I. M. S. (2020) · Journal of Immunological Methods · doi:10.1016/j.jim.2020.112753 · Cited by 45
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Filderman, J. N., Appleman, M., Chelvanambi, M., Taylor, J. L., & Storkus, W. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690105 · Cited by 45
Henriksen, J. R., Nederby, L., Donskov, F. N., Waldstrøm, M., Adimi, P., Jakobsen, A. K. M., & Steffensen, K. D. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00661-4 · Cited by 44
Pimenta, E. M., De, S., Weiss, R., Feng, D., Hall, K. L., Kilic, S. S., Bhanot, G., Ganesan, S., Ran, S., & Barnes, B. J. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.110 · Cited by 44
Autoantibodies in cancer: prognostic biomarkers and immune activation
Järås, K., & Anderson, K. S. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.48 · Cited by 44
The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities
Flynn, N. J., Somasundaram, R., Arnold, K. M., & Sims‐Mourtada, J. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0481-x · Cited by 44
Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer
Wilke, C. M., Kryczek, I., & Zou, W. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.567362 · Cited by 43
Quan, H., Fang, L., Pan, H., Deng, Z., Gao, S., Liu, O., Wang, Y., Hu, Y., Fang, X., Yao, Z., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30019 · Cited by 43
Roselli, E., Araya, P., Núñez, N. G., Gatti, G., Graziano, F., Sedlik, C., Benaroch, P., Piaggio, E., & Maccioni, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00503 · Cited by 43
Maletzki, C., Jahnke, A., Ostwald, C., Klar, E., Prall, F., & Linnebacher, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032639 · Cited by 42
Ding, Q., Mohib, K., Kuchroo, V. K., & Rothstein, D. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602107 · Cited by 42
Sulaieva, O., Selezniov, O., Shapochka, D., Belemets, N. I., Nechay, O. P., Васильевна, Ч. Е., Tsomartova, D. A., & Ivanova, M. Y. (2020) · Heliyon · doi:10.1016/j.heliyon.2019.e03077 · Cited by 41
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
Minici, C., Rigamonti, E., Lanzillotta, M., Monno, A., Rovati, L., Maehara, T., Kaneko, N., Deshpande, V., Protti, M. P., Monte, L. B. D., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1794359 · Cited by 41
Uttam, S., Stern, A. M., Sevinsky, C. J., Furman, S. A., Pullara, F., Spagnolo, D. M., Nguyen, L., Gough, A., Ginty, F., Taylor, D. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17083-x · Cited by 41
Nelson, B. H. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.004 · Cited by 41
Self-citationTumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment
Xue, D., Hu, S., Zheng, R., Luo, H., & Ren, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117436 · Cited by 39
B Cells Promote Tumor Immunity against B16F10 Melanoma
Kobayashi, T., Hamaguchi, Y., Hasegawa, M., Fujimoto, M., Takehara, K., & Matsushita, T. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.07.003 · Cited by 39
Wu, X., Shi, X., Zhai, K., Yi, F., Wang, Z., Wang, W., Pei, X., Xu, L., Wang, Z., & Shi, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00120.2018 · Cited by 38
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
Coleman, M. F., Cozzo, A. J., Pfeil, A. J., Etigunta, S. K., & Hursting, S. D. (2020) · Cancers · doi:10.3390/cancers12040852 · Cited by 38
Huang, M., Peng, X., Yang, L., Yang, S., Li, X., Tang, S., Li, B., Jin, H., Wu, B., Liu, J., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.005 · Cited by 39
Казакова, А., Sudarskikh, T., Kovalev, O. I., Kzhyshkowska, J. G., & Larionova, I. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5480 · Cited by 38
Woo, S., Cha, S. W., Bonissone, S. R., Na, S., Tabb, D. L., Pevzner, P. A., & Bafna, V. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00264 · Cited by 37
Engineering cancer vaccines using stimuli-responsive biomaterials
Zhao, Y., Guo, Y., & Tang, L. (2018) · Nano Research · doi:10.1007/s12274-018-2162-1 · Cited by 37
Schoenberg, M. B., Hao, J., Bucher, J. N., Miksch, R. C., Anger, H. J. W., Mayer, B., Mayerle, J. V., Neumann, J. H. L., Guba, M. O., Werner, J., et al. (2018) · Cancers · doi:10.3390/cancers10100389 · Cited by 37
Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
Fialová, A., Koucký, V., Hajdůšková, M., Hladíková, K., & Špíšek, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01701 · Cited by 37
Tudor, C. S., Distel, L. V., Eckhardt, J., Hartmann, A., Niedobitek, G., & Buettner, M. J. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.06.006 · Cited by 36
Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value
Трајковски, Ѓ., Ognjenovic, L., Karadžov, Z., Jota, G., Hadzi-Manchev, D., Костовски, О., Volcevski, G., Trajkovska, V., Nikolova, D., Spasevska, L., et al. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.341 · Cited by 35
Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications
Bida, M., Miya, T. V., Hull, R., & Dlamini, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1497522 · Cited by 34
Premkumar, K., & Shankar, B. S. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02666-w · Cited by 34
Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma
Theurich, S., Schlaak, M. S., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Rabenhorst, A., Hartmann, K., Schlößer, H., Shimabukuro‐Vornhagen, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.9471 · Cited by 34
Zhu, J., Zhang, K., Chen, Y., Ge, X., Wu, J., Xu, P., & Yao, J. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05307-3 · Cited by 34
Extracellular Vesicles Orchestrate Immune and Tumor Interaction Networks
Yim, K. H. W., Hrout, A. A., Borgoni, S., & Chahwan, R. (2020) · Cancers · doi:10.3390/cancers12123696 · Cited by 33
B cell-derived cytokines in disease
Hamze, M., Desmetz, C., & Guglielmi, P. (2013) · European Cytokine Network · doi:10.1684/ecn.2013.0327 · Cited by 33
Immunotherapy in mastitis: state of knowledge, research gaps and way forward
Saleem, A., Saleem, S., Omonijo, F. A., Ganai, N. A., Ibeagha-Awemu, E. M., & Ahmad, S. M. (2024) · Veterinary Quarterly · doi:10.1080/01652176.2024.2363626 · Cited by 33
Guy, T. V., Terry, A. M., Bolton, H. A., Hancock, D. G., Shklovskaya, E., & Groth, B. F. D. S. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1848-z · Cited by 32
Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression
Zahari, S., Syafruddin, S. E., & Mohtar, M. A. (2023) · Cancers · doi:10.3390/cancers15092653 · Cited by 32
Hou, X., Li, X., Han, Y., Xu, H., Xie, Y., Zhou, T., Xue, T., Qian, X., Li, J., Wang, C., et al. (2024) · Cancer · doi:10.1002/cncr.35261 · Cited by 32
Regulatory B Lymphocytes: Development and Modulation of the Host Immune Response During Disease
Moore, D. K., & Loxton, A. G. (2019) · Immunotherapy · doi:10.2217/imt-2018-0185 · Cited by 31
Tumor-infiltrating B cells come into vogue
Linnebacher, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i1.8 · Cited by 31
B cells and antibody production in melanoma
Duarte, J. D. G., Peyper, J. M., & Blackburn, J. M. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9778-z · Cited by 31
Helper T cells in malignant pleural effusion
Yi, F., Zhai, K., & Shi, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.016 · Cited by 30
Jeschke, J., Collignon, É., & Fuks, F. (2014) · FEBS Journal · doi:10.1111/febs.13125 · Cited by 30
Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-cell Response
Deng, J., Yuan, S., Pennati, A., Murphy, J. R., Wu, J. H., Lawson, D. H., & Galipeau, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0708 · Cited by 30
Metadata
- Authors
- Nelson, B. H.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Nelson, Brad H
- ORCID
- Nelson, Brad H
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-01
- Volume
- 185
- Issue
- 9
- Pages
- 4977-4982
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2107894271
- Semantic Scholar
- bf7939d1d9b47655a2abef372b8ceeacdc5af79b
- Cited by
- 416
- References
- 96
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 20 · 2023: 27 · 2022: 26 · 2021: 25 · 2020: 47 · 2019: 35 · 2018: 30 · 2017: 23 · 2016: 36 · 2015: 30 · 2014: 31 · 2013: 24 · 2012: 17
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD20+ B cells, tumor-infiltrating lymphocytes, tertiary lymphoid structures, tumor microenvironment, autoimmunity, organ transplantation, antigen presentation, chemokines, cytokines, tumor immunology
- MeSH terms
- Animals, B-Lymphocytes, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Autoimmunity, B-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Antigens, CD20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.